CN104906132B - A kind of plaster for preventing and treating lamb stomatitis - Google Patents
A kind of plaster for preventing and treating lamb stomatitis Download PDFInfo
- Publication number
- CN104906132B CN104906132B CN201510320483.8A CN201510320483A CN104906132B CN 104906132 B CN104906132 B CN 104906132B CN 201510320483 A CN201510320483 A CN 201510320483A CN 104906132 B CN104906132 B CN 104906132B
- Authority
- CN
- China
- Prior art keywords
- stomatitis
- iodine
- lamb
- menthol
- tincture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000003265 stomatitis Diseases 0.000 title claims abstract description 31
- 235000019687 Lamb Nutrition 0.000 title claims abstract description 27
- 239000011505 plaster Substances 0.000 title claims abstract description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 42
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims abstract description 29
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 27
- 229940041616 menthol Drugs 0.000 claims abstract description 27
- 239000000230 xanthan gum Substances 0.000 claims abstract description 20
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 20
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 20
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 20
- 239000000203 mixture Substances 0.000 claims abstract description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000015110 jellies Nutrition 0.000 claims abstract description 13
- 239000008274 jelly Substances 0.000 claims abstract description 13
- 239000011259 mixed solution Substances 0.000 claims abstract description 13
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 10
- 239000011630 iodine Substances 0.000 claims abstract description 10
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims abstract 6
- 235000011187 glycerol Nutrition 0.000 claims description 17
- 238000002360 preparation method Methods 0.000 claims description 17
- 239000000243 solution Substances 0.000 claims description 16
- 239000003814 drug Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 7
- 239000008213 purified water Substances 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 3
- 229940098465 tincture Drugs 0.000 abstract description 11
- 230000002265 prevention Effects 0.000 abstract description 4
- 241000894006 Bacteria Species 0.000 abstract description 3
- 206010030113 Oedema Diseases 0.000 abstract description 3
- 241000700605 Viruses Species 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 230000002147 killing effect Effects 0.000 abstract description 3
- 230000001139 anti-pruritic effect Effects 0.000 abstract description 2
- 238000002156 mixing Methods 0.000 abstract description 2
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 239000003908 antipruritic agent Substances 0.000 abstract 1
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 22
- 241001494479 Pecora Species 0.000 description 15
- 239000002674 ointment Substances 0.000 description 13
- 241000283903 Ovis aries Species 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- 210000000214 mouth Anatomy 0.000 description 6
- 210000004400 mucous membrane Anatomy 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 4
- 244000246386 Mentha pulegium Species 0.000 description 4
- 235000016257 Mentha pulegium Nutrition 0.000 description 4
- 235000004357 Mentha x piperita Nutrition 0.000 description 4
- 230000036760 body temperature Effects 0.000 description 4
- 235000001050 hortel pimenta Nutrition 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 241000283707 Capra Species 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 235000021266 loss of appetite Nutrition 0.000 description 3
- 210000002200 mouth mucosa Anatomy 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010059866 Drug resistance Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010039424 Salivary hypersecretion Diseases 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 241000589634 Xanthomonas Species 0.000 description 2
- 229940037003 alum Drugs 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- -1 iodine-menthol Chemical compound 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 239000012286 potassium permanganate Substances 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 208000026451 salivation Diseases 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 150000003456 sulfonamides Chemical class 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 108010077805 Bacterial Proteins Proteins 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- DKNPRRRKHAEUMW-UHFFFAOYSA-N Iodine aqueous Chemical compound [K+].I[I-]I DKNPRRRKHAEUMW-UHFFFAOYSA-N 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 241001647875 Pseudoxanthomonas Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241000589636 Xanthomonas campestris Species 0.000 description 1
- YADZBEISHVCBSJ-UHFFFAOYSA-N [I].OCC(O)CO Chemical compound [I].OCC(O)CO YADZBEISHVCBSJ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000010564 aerobic fermentation Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000002026 carminative effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- ZXJXZNDDNMQXFV-UHFFFAOYSA-M crystal violet Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1[C+](C=1C=CC(=CC=1)N(C)C)C1=CC=C(N(C)C)C=C1 ZXJXZNDDNMQXFV-UHFFFAOYSA-M 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000003640 drug residue Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229960001235 gentian violet Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 230000023247 mammary gland development Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229960000282 metronidazole Drugs 0.000 description 1
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 230000008533 pain sensitivity Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000022676 rumination Effects 0.000 description 1
- 208000015212 rumination disease Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
技术领域technical field
本发明属于兽药技术领域,具体涉及一种防治羔羊口炎的膏药制剂。The invention belongs to the technical field of veterinary medicine, and in particular relates to a plaster preparation for preventing and treating lamb stomatitis.
背景技术Background technique
羊口炎是口腔黏膜表层和深层组织的炎症。在病理过程中,口腔黏膜和齿龈发炎,可使病羊采食和咀嚼困难,口流清涎,痛觉敏感性增高。临床常见单纯性局部炎症和继发性全身反应。初生羔羊一周以内主要依靠哺乳获得营养,一周后,随着羔羊逐渐长大,开始模仿母羊采食饲料、啃咬各种形状的物件。但由于初生羔羊的口部皮肤粘膜特别细嫩,极容易受伤破损,受感染后发生口炎。一旦感染口炎,病羊表现食欲减少,口内流涎,咀嚼缓慢,由于疼痛而不愿采食,有时还会继发口臭。如果病羊不能得到及时的医治,病羊就会发生食欲减退甚至全无、反刍减少、被毛无光杂乱、逐渐消瘦,最终致使病羔羊饿死。Mouth stomatitis is an inflammation of the surface and deep tissues of the oral mucosa. In the pathological process, the oral mucosa and gums are inflamed, which can make it difficult for sick sheep to eat and chew, salivation clears the mouth, and pain sensitivity increases. Simple local inflammation and secondary systemic reactions are common clinically. Newborn lambs mainly rely on breastfeeding for nutrition within a week. After a week, as the lambs grow up, they begin to imitate ewes to eat feed and bite objects of various shapes. However, because the skin and mucous membranes of the mouth of newborn lambs are particularly delicate, they are very easy to be injured and damaged, and stomatitis will occur after infection. Once infected with stomatitis, sick sheep show loss of appetite, salivation in the mouth, slow chewing, reluctance to eat because of pain, and sometimes secondary halitosis. If the sick sheep cannot be treated in time, the sick sheep will have loss of appetite or even no appetite, reduced rumination, dull and messy coat, and gradually become emaciated, and eventually the sick lamb will starve to death.
目前在养羊生产中,防治羔羊口炎主要使用一些消毒剂,如轻度口炎可用0.1%的雷佛奴尔或0.1%高锰酸钾溶液洗涤口腔,亦可以用2%的明矾冲洗;发生糜烂和渗出时,用2%的明矾冲洗;口腔黏膜有溃疡时,可用碘甘油、5%碘酊、龙胆紫溶液、磺胺软膏、四环素软膏等涂擦患部;如继发细菌感染,病羊体温升高时,可用青霉素、链霉素等进行肌肉注射,每天2次,连用3~5天,也可服用或注射磺胺类药物。At present, in the production of sheep, some disinfectants are mainly used to prevent and treat lamb stomatitis. For mild stomatitis, the mouth can be washed with 0.1% Ravenul or 0.1% potassium permanganate solution, or rinsed with 2% alum; When erosion and exudation occur, rinse with 2% alum; when oral mucosa has ulcers, use iodine glycerin, 5% iodine tincture, gentian violet solution, sulfonamide ointment, tetracycline ointment, etc. to rub the affected part; When the sheep's body temperature rises, penicillin, streptomycin, etc. can be used for intramuscular injection, twice a day, for 3 to 5 consecutive days, and sulfa drugs can also be taken or injected.
在利用以上方法防治羔羊口炎的过程中发现,以上所述的各类常用消毒剂有的不容易在患病部位附着,更不能在病患部位形成保护性的覆盖,从而不能在患病部位停留较长的时间发挥药效,疗效较慢;其他如磺胺类、四环素类软膏由于其味苦,对羔羊有一定的刺激性,而且经常使用容易产生抗药性。而抗生素类药物的使用,又很容易导致抗(耐)药性和养殖类药残超标等问题,甚至影响母羔的乳腺发育,不符合动物福利、发展无公害养殖业、生产绿色水产品的需求。In the process of using the above methods to prevent and treat lamb stomatitis, it was found that some of the above-mentioned commonly used disinfectants are not easy to adhere to the diseased part, let alone form a protective cover on the diseased part, so that they cannot be used on the diseased part. Stay for a long time to exert the drug effect, and the curative effect is slow; other ointments such as sulfonamides and tetracyclines are irritating to lambs due to their bitter taste, and they are prone to drug resistance when used frequently. The use of antibiotics can easily lead to problems such as drug resistance (resistance) and breeding drug residues exceeding the standard, and even affect the mammary gland development of ewes, which does not meet the needs of animal welfare, the development of pollution-free aquaculture, and the production of green aquatic products. .
发明内容Contents of the invention
针对现有技术防治羔羊口炎中存在的技术缺陷,本发明的目的在于提供一种成本低廉、方便使用、效果显著的防治羔羊口炎的药膏,及该药膏的制备方法,本发明制备的药膏实践应用效果好、成本低、容易加工生产,具有较好的市场前景。Aiming at the technical defects existing in the prevention and treatment of lamb stomatitis in the prior art, the purpose of the present invention is to provide a low-cost, easy-to-use and effective ointment for the prevention and treatment of lamb stomatitis, and the preparation method of the ointment. The ointment prepared by the present invention The practical application effect is good, the cost is low, easy to process and produce, and has a good market prospect.
本发明具体通过以下技术方案实现:The present invention is specifically realized through the following technical solutions:
一种防治羔羊口炎的膏药制剂,由以下成分组成:碘酊25~75ml、甘油25~75ml、薄荷脑1~3g、黄原胶1~3g、纯净水25~75ml。A plaster preparation for preventing and treating lamb stomatitis, which consists of the following components: 25-75ml of tincture of iodine, 25-75ml of glycerin, 1-3g of menthol, 1-3g of xanthan gum, and 25-75ml of purified water.
所述的碘酊中碘的质量浓度为20g/L,即2%的碘酊。The mass concentration of iodine in the described iodine tincture is 20g/L, i.e. 2% iodine tincture.
所述的药膏主要用于治疗出生后至60日龄内的羔羊口炎。The ointment is mainly used for treating lamb stomatitis from birth to 60 days of age.
该防治羔羊口炎的膏药制剂通过以下方法制备:The plaster preparation for preventing and treating lamb stomatitis is prepared by the following method:
1)将1~3g薄荷脑溶解于25~75ml浓度为2%的碘酊中,得到碘酊薄荷脑溶液;1) dissolving 1-3g of menthol in 25-75ml of tincture of iodine with a concentration of 2% to obtain an iodine-menthol solution;
2)量取25~75ml的甘油与步骤(1)制成的碘酊薄荷脑溶液混匀,得到混合溶液;2) Measure 25-75ml of glycerin and mix with the iodine-menthol solution made in step (1) to obtain a mixed solution;
3)称取1~3g黄原胶溶解于25~75ml水中,充分溶解,得到胶状物;3) Weigh 1-3g of xanthan gum and dissolve it in 25-75ml of water, fully dissolve to obtain jelly;
4)将步骤(2)得到混合溶液与第(3)步制成的胶状物充分混合,即得。4) Thoroughly mix the mixed solution obtained in step (2) with the jelly produced in step (3).
优选的,一种防治羔羊口炎的膏药制剂,由以下成分组成:碘酊50ml、甘油50ml、薄荷脑2g、黄原胶2g、纯净水50ml。Preferably, a plaster preparation for preventing and treating lamb stomatitis is composed of the following components: 50ml of tincture of iodine, 50ml of glycerin, 2g of menthol, 2g of xanthan gum, and 50ml of purified water.
所述的碘酊中碘的质量浓度为20g/L,即2%的碘酊。The mass concentration of iodine in the described iodine tincture is 20g/L, i.e. 2% iodine tincture.
所述的药膏主要用于治疗出生后至60日龄内的羔羊口炎。The ointment is mainly used for treating lamb stomatitis from birth to 60 days of age.
该防治羔羊口炎的膏药制剂通过以下方法制备:The plaster preparation for preventing and treating lamb stomatitis is prepared by the following method:
1)将2g薄荷脑溶解于50ml浓度为2%的碘酊中,得到碘酊薄荷脑溶液;1) dissolving 2g menthol in 50ml concentration of 2% iodine tincture to obtain iodine tincture menthol solution;
2)量取50ml的甘油与步骤(1)制成的碘酊薄荷脑溶液混匀,得到混合溶液;2) Measure the glycerin of 50ml and mix with the iodine tincture menthol solution made in step (1) to obtain a mixed solution;
3)称取2g黄原胶溶解于50ml水中,充分溶解,得到胶状物;3) Weigh 2g of xanthan gum and dissolve it in 50ml of water, fully dissolve to obtain jelly;
4)将步骤(2)得到混合溶液与第(3)步制成的胶状物充分混合,即得。4) Thoroughly mix the mixed solution obtained in step (2) with the jelly produced in step (3).
本发明药膏中的碘酊,碘酊俗称碘酒,医学上一般称碘酊,是用于皮肤感染和消毒的消毒防腐剂,是由碘、碘化钾溶解于酒精而制成的2%溶液。其作用机制是使菌体蛋白质变性,死亡,对细菌、病毒均有杀灭作用。碘酊的功能主要用作皮肤及注射前、手术部位的消毒。The tincture of iodine in the ointment of the present invention, tincture of iodine is commonly called as iodine wine, is generally called tincture of iodine in medicine, is the antiseptic antiseptic used for skin infection and disinfection, is the 2% solution that is made by dissolving iodine and potassium iodide in alcohol. Its mechanism of action is to denature and kill bacterial proteins, and it has a killing effect on bacteria and viruses. The function of iodine tincture is mainly used for disinfection of the skin, before injection, and the surgical site.
甘油,丙三醇是无色味甜澄明黏稠液体,无臭,有暖甜味,俗称甘油,能从空气中吸收潮气,是多种护肤用品的组成成分。Glycerin, glycerol is a colorless, sweet, clear, viscous liquid, odorless, with a warm sweet taste, commonly known as glycerin, which can absorb moisture from the air, and is a component of many skin care products.
薄荷脑,一种化学药剂,薄荷脑系由薄荷的叶和茎中所提取,白色晶体,分子式C10H20O,为薄荷和欧薄荷精油中的主要成分。在世界上,印度是主要的天然薄荷生产国。薄荷脑和消旋薄荷脑均可用作牙膏;香水;饮料和糖果等的赋香剂。在医药上用作刺激药,作用于皮肤或粘膜,有清凉止痒作用;内服可作为驱风药,用于头痛及鼻;咽;喉炎症等。其酯用于香料和药物。薄荷脑能选择性地刺激人体皮肤或黏膜的冷觉感受器,产生冷觉反射和冷感,引起皮肤黏膜血管收缩(实际上皮肤保持正常);另外对深部组织的血管也可引起收缩,而产生治疗作用。外用可以消炎,止痛,止痒,促进血液循环,减轻浮肿等。Menthol, a chemical agent, is extracted from the leaves and stems of peppermint. It is a white crystal with a molecular formula of C 10 H 20 O. It is the main component of peppermint and peppermint essential oils. In the world, India is the major producer of natural peppermint. Both menthol and racemic menthol can be used as toothpaste; perfume; flavoring agent for beverages and candies. It is used as a stimulant in medicine, acting on the skin or mucous membranes, and has a cooling and antipruritic effect; it can be used as a carminative when taken orally, for headaches and nose; pharynx; laryngitis, etc. Its esters are used in fragrances and medicines. Menthol can selectively stimulate the cold receptors of human skin or mucous membranes, produce cold reflection and cold sensation, and cause skin and mucous membrane blood vessels to constrict (actually the skin remains normal); in addition, it can also cause contraction of blood vessels in deep tissues, resulting in Therapeutic effect. External use can reduce inflammation, relieve pain, relieve itching, promote blood circulation, reduce edema, etc.
黄原胶,又称黄胶、汉生胶,黄单胞多糖,是一种由假黄单胞菌属发酵产生的单孢多糖,由甘蓝黑腐病野油菜黄单胞菌以碳水化合物为主要原料,经好氧发酵生物工程技术,切断1,6-糖苷键,打开支链后,在按1,4-键合成直链组成的一种酸性胞外杂多糖。黄原胶是由糖类经黄单胞杆菌发醉,产生的胞外微生物多塘。由于它的大分子特殊结构和胶体特性,而具有多种功能,可作为乳化剂、稳定剂、凝胶增稠剂、浸润剂、膜成型剂等。黄原胶被誉为“工业味精”,是目前世界上生产规模最大且用途极为广泛的微生物多糖。在医药制品中,可作为定型剂、悬浮剂、保湿剂,具有增稠、附着、润滑作用,提高膏剂的附着性能,分散性好。Xanthan gum, also known as xanthan gum, xanthan gum, and xanthomonas polysaccharide, is a monospore polysaccharide produced by the fermentation of Pseudoxanthomonas, which is produced by Xanthomonas campestris spp. The main raw material, through aerobic fermentation bioengineering technology, cuts 1,6-glucosidic bonds, opens branched chains, and then presses 1,4-bonds to form an acidic extracellular heteropolysaccharide composed of straight chains. Xanthan gum is an extracellular microbial polypond produced by the intoxication of sugars by Xanthomonas bacteria. Due to its special macromolecular structure and colloidal properties, it has multiple functions, and can be used as an emulsifier, stabilizer, gel thickener, wetting agent, film forming agent, etc. Xanthan gum, known as "industrial monosodium glutamate", is currently the world's largest microbial polysaccharide with a wide range of uses. In pharmaceutical products, it can be used as a setting agent, suspending agent, and moisturizing agent. It has the functions of thickening, adhesion, and lubrication, and can improve the adhesion of ointments and has good dispersibility.
本发明的有益效果为:本发明药膏以清热解毒为主,可消炎,止痛,止痒,促进血液循环,减轻浮肿,对细菌、病毒均有杀灭作用,对于治疗出生后至60日龄内的羔羊口炎具有显著的疗效。同时本发明膏剂便于使用,具有长效作用,方便简单,制备过程简单,易于推广使用。The beneficial effects of the present invention are: the ointment of the present invention is mainly used for clearing heat and detoxifying, can reduce inflammation, relieve pain, relieve itching, promote blood circulation, reduce edema, and have a killing effect on bacteria and viruses. Lamb stomatitis has a significant curative effect. Simultaneously, the ointment of the present invention is convenient to use, has long-acting effects, is convenient and simple, has a simple preparation process, and is easy to popularize and use.
具体实施方式Detailed ways
下面结合实施例对本发明做进一步的说明,以下所述,仅是对本发明的较佳实施例而已,并非对本发明做其他形式的限制,任何熟悉本专业的技术人员可能利用上述揭示的技术内容加以变更为同等变化的等效实施例。凡是未脱离本发明方案内容,依据本发明的技术实质对以下实施例所做的任何简单修改或等同变化,均落在本发明的保护范围内。The present invention will be further described below in conjunction with the embodiments. The following descriptions are only preferred embodiments of the present invention, and are not intended to limit the present invention to other forms. Changes to equivalent embodiments with equivalent changes. Any simple modifications or equivalent changes made to the following embodiments according to the technical essence of the present invention without departing from the solution content of the present invention fall within the protection scope of the present invention.
实施例1Example 1
一种防治羔羊口炎的膏药制剂,由以下成分组成:碘酊50ml、甘油50ml、薄荷脑2g、黄原胶2g、纯净水50ml。A plaster preparation for preventing and treating lamb stomatitis, which consists of the following components: 50ml of tincture of iodine, 50ml of glycerin, 2g of menthol, 2g of xanthan gum, and 50ml of purified water.
通过以下方法制备:Prepared by:
1)将2g薄荷脑溶解于50ml浓度为2%的碘酊中,得到碘酊薄荷脑溶液;1) dissolving 2g menthol in 50ml concentration of 2% iodine tincture to obtain iodine tincture menthol solution;
2)量取50ml的甘油与步骤(1)制成的碘酊薄荷脑溶液混匀,得到混合溶液;2) Measure the glycerin of 50ml and mix with the iodine tincture menthol solution made in step (1) to obtain a mixed solution;
3)称取2g黄原胶溶解于50ml水中,充分溶解,得到胶状物;3) Weigh 2g of xanthan gum and dissolve it in 50ml of water, fully dissolve to obtain jelly;
4)将步骤(2)得到混合溶液与第(3)步制成的胶状物充分混合,即得。4) Thoroughly mix the mixed solution obtained in step (2) with the jelly produced in step (3).
实施例2Example 2
一种防治羔羊口炎的膏药制剂,由以下成分组成:碘酊25ml、甘油75ml、薄荷脑1g、黄原胶3g、纯净水25ml。A plaster preparation for preventing and treating lamb stomatitis, which consists of the following components: 25ml of tincture of iodine, 75ml of glycerin, 1g of menthol, 3g of xanthan gum, and 25ml of purified water.
通过以下方法制备:Prepared by:
1)将1g薄荷脑溶解于25ml浓度为2%的碘酊中,得到碘酊薄荷脑溶液;1) 1g of menthol is dissolved in 25ml of iodine tincture with a concentration of 2%, to obtain iodine tincture of menthol;
2)量取75ml的甘油与步骤(1)制成的碘酊薄荷脑溶液混匀,得到混合溶液;2) Measure the glycerol of 75ml and mix with the iodine tincture menthol solution made in step (1) to obtain a mixed solution;
3)称取3g黄原胶溶解于25ml水中,充分溶解,得到胶状物;3) Weigh 3g of xanthan gum and dissolve it in 25ml of water, fully dissolve to obtain jelly;
4)将步骤(2)得到混合溶液与第(3)步制成的胶状物充分混合,即得。4) Thoroughly mix the mixed solution obtained in step (2) with the jelly produced in step (3).
实施例3Example 3
一种防治羔羊口炎的膏药制剂,由以下成分组成:碘酊75ml、甘油25ml、薄荷脑3g、黄原胶1g、纯净水75ml。A plaster preparation for preventing and treating lamb stomatitis, which consists of the following components: 75ml of tincture of iodine, 25ml of glycerin, 3g of menthol, 1g of xanthan gum, and 75ml of purified water.
通过以下方法制备:Prepared by:
1)将3g薄荷脑溶解于75ml浓度为2%的碘酊中,得到碘酊薄荷脑溶液;1) dissolving 3g menthol in 75ml concentration of 2% iodine tincture to obtain iodine tincture menthol solution;
2)量取25ml的甘油与步骤(1)制成的碘酊薄荷脑溶液混匀,得到混合溶液;2) Measure 25ml of glycerin and mix with the iodine tincture menthol solution made in step (1) to obtain a mixed solution;
3)称取1g黄原胶溶解于75ml水中,充分溶解,得到胶状物;3) Weigh 1g of xanthan gum and dissolve it in 75ml of water, fully dissolve to obtain jelly;
4)将步骤(2)得到混合溶液与第(3)步制成的胶状物充分混合,即得。4) Thoroughly mix the mixed solution obtained in step (2) with the jelly produced in step (3).
下面结合具体的实施例对本发明药膏的治疗效果做进一步的说明。The therapeutic effect of the ointment of the present invention will be further described below in conjunction with specific examples.
实施例4治疗效果实验Embodiment 4 therapeutic effect experiment
在山东省青岛市崂山区某奶山羊养殖场选取出生后至60日龄内的羔羊,从中挑选确诊后的患有口炎的羔羊200头作为治疗对象,将随机挑选的200头患有口炎的羔羊分为4组(实施例1组、实施例2组、实施例3组和对照组),每组50头,其中实施例1~3组分别使用本发明实施例1~3所得膏药进行治疗,夜晚期间在患病处敷用,每天换药一次;对照组采用西药治疗,将每片净重0.2g的25片甲硝唑研磨成粉末状,混入30ml温水中进行搅拌,最后加入70ml甘油混合配制成浓度为0.5%的甲硝唑甘油合剂,先用浓度0.2%高锰酸钾冲洗病羊口腔之后,在其患部涂擦甲硝唑甘油合剂,每天早晚各1次。观察记录各组羊的治愈率和治愈时间,结果如表1所示。In a milk goat farm in Laoshan District, Qingdao City, Shandong Province, lambs were selected from birth to 60 days old, and 200 lambs diagnosed with stomatitis were selected as treatment objects, and 200 randomly selected lambs with stomatitis were selected. Lamb is divided into 4 groups (embodiment 1 group, embodiment 2 groups, embodiment 3 groups and control group), every group of 50, wherein embodiment 1~3 groups use the plaster obtained from embodiment 1~3 of the present invention to carry out respectively. For treatment, apply it on the affected area at night, and change the dressing once a day; the control group is treated with western medicine, grinding 25 tablets of metronidazole each with a net weight of 0.2g into powder, mixing it into 30ml of warm water for stirring, and finally adding 70ml of glycerin Mix and prepare a metronidazole-glycerin mixture with a concentration of 0.5%, rinse the oral cavity of the sick sheep with 0.2% potassium permanganate, and rub the metronidazole-glycerin mixture on the affected part, once a day in the morning and evening. The cure rate and cure time of each group of sheep were observed and recorded, and the results are shown in Table 1.
疗效判定标准:Efficacy Judgment Criteria:
痊愈:患羊经过1周的治疗后,其口腔症状消失,能够正常进食,体温恢复正常。Recovery: After 1 week of treatment, the sheep's oral symptoms disappeared, they could eat normally, and their body temperature returned to normal.
有效:患羊的口腔症状基本消失,进食量与治疗前比较增加,体温恢复正常。Effective: The oral symptoms of affected sheep basically disappeared, the food intake increased compared with before treatment, and the body temperature returned to normal.
无效:患羊经过1周的治疗后,其口腔症状仍存在,且体温较高,进食量无增加。Ineffective: After 1 week of treatment, the affected sheep still had oral symptoms, and their body temperature was high, and their food intake did not increase.
表1治疗效果统计Table 1 Treatment effect statistics
从表1的数据可知:本发明的膏药对羊口炎治疗效果明显优于西药治疗组,同时治疗实验明显短于对照组,说明本发明膏药在药物的长效和吸收上具有明显效果。As can be seen from the data of table 1: plaster of the present invention is obviously better than western medicine treatment group to amniotic stomatitis therapeutic effect, and treatment experiment is obviously shorter than matched group simultaneously, illustrates that plaster of the present invention has obvious effect on long-acting and absorption of medicine.
实施例5防治效果实验Embodiment 5 control effect experiment
在山东省青岛市崂山区某奶山羊养殖场随机选取刚出生后的健康羔羊200,将随机挑选的200头羔羊分为4组(实施例1组、实施例2组、实施例3组和对照组),每组50头,其中实施例1~3组分别使用本发明实施例1~3所得膏药进行防治,每天夜晚在羊唇内敷用一次;对照组不使用任何药物,连用10天后,取山羊的病料悬浮液,对实施例组1、实施例组2、实施例组3和对照组的羊在羊唇内粘膜划痕接种,观察记录各组羊的发病率,结果如表2所示。Randomly select 200 healthy lambs just after birth in a dairy goat farm in Laoshan District, Qingdao City, Shandong Province, and divide the 200 lambs selected at random into 4 groups (embodiment 1 group, embodiment 2 groups, embodiment 3 groups and contrast) Group), every group of 50, wherein embodiment 1~3 groups use respectively the plaster gained in the embodiment of the present invention 1~3 to carry out prevention and treatment, apply once in the sheep lip every night; Control group does not use any medicine, after 10 consecutive days, Get the disease material suspension of goats, and inoculate the sheep of embodiment group 1, embodiment group 2, embodiment group 3 and control group in the mucous membrane scratches of the sheep lips, observe and record the incidence rate of each group of sheep, and the results are shown in Table 2 shown.
表2预防效果统计数据Table 2 Statistical data of preventive effect
从表2的数据可知:本发明的中药组合物对羊口炎有明显的预防效果。From the data in Table 2, it can be seen that the traditional Chinese medicine composition of the present invention has an obvious preventive effect on stomatitis.
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510320483.8A CN104906132B (en) | 2015-06-11 | 2015-06-11 | A kind of plaster for preventing and treating lamb stomatitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510320483.8A CN104906132B (en) | 2015-06-11 | 2015-06-11 | A kind of plaster for preventing and treating lamb stomatitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104906132A CN104906132A (en) | 2015-09-16 |
| CN104906132B true CN104906132B (en) | 2018-11-16 |
Family
ID=54075852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510320483.8A Expired - Fee Related CN104906132B (en) | 2015-06-11 | 2015-06-11 | A kind of plaster for preventing and treating lamb stomatitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104906132B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109793838A (en) * | 2019-02-22 | 2019-05-24 | 青岛农业大学 | A kind of plaster preparation for preventing and treating Tibetan antelope stomatitis and preparation method thereof |
| CN110201190B (en) * | 2019-06-27 | 2021-12-14 | 施瑞华 | Coloring agent for early diagnosis of esophageal cancer and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1481812A (en) * | 2003-07-23 | 2004-03-17 | �Ϻ���ͨ��ѧ | povidone iodine spray |
-
2015
- 2015-06-11 CN CN201510320483.8A patent/CN104906132B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1481812A (en) * | 2003-07-23 | 2004-03-17 | �Ϻ���ͨ��ѧ | povidone iodine spray |
Non-Patent Citations (3)
| Title |
|---|
| 复方薄荷脑碘滴鼻液的制备及质量控制;薛艳丽;《中国医院药学杂志》;20071231;第27卷(第12期);第1748页 * |
| 羊口炎症状及防治;张守印;《吉林农村报》;20140411;第1页 * |
| 羊口炎的预防与治疗;肖晓薇;《当代畜禽养殖业》;20130228;第6页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104906132A (en) | 2015-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103025386B (en) | Be used for the treatment of the tamarind seed polysaccharide of infected by microbes | |
| CN101444555B (en) | A kind of pure Chinese medicinal film for treating oral ulcer and preparation method thereof | |
| CN109512683B (en) | Povidone-iodine composition and preparation method and application thereof | |
| CN109481527B (en) | Traditional Chinese medicine composition for preventing or treating oral diseases and application thereof | |
| CN1927160A (en) | Gargle and its preparing process | |
| CN104906132B (en) | A kind of plaster for preventing and treating lamb stomatitis | |
| CN110787288A (en) | Medical collagen oral ulcer protective gel and preparation method thereof | |
| CN111557877A (en) | Toothpaste containing centella extract and preparation method thereof | |
| CN116236439A (en) | Colloidal silver antibacterial gel and preparation method and application thereof | |
| CN104906131B (en) | A kind of preparation method preventing and treating lamb stomatitis plaster | |
| CN106491634B (en) | Hyaluronic Acid dimethyl-silicon alkanol compound and combinations thereof | |
| CN108366991B (en) | Synergistic compounds of pyrrolidone carboxylic acid and/or its salts and hyaluronic acid and/or its salts for the treatment and/or prevention of mucous membrane drying and irritation, and related pharmaceutical formulations | |
| CN108938703A (en) | The gynecological gel of quick antibacterial | |
| CN108420768A (en) | A kind of shield gum toothpaste of anti-inflammation hemostasia and preparation method thereof | |
| CN109223760B (en) | A kind of purposes of benzofuran derivative | |
| CN107951733A (en) | The preparation and its application of Azulene sodium sulfonate and Cetylpyridinium Chloride compound mouthwash | |
| EP3618806B1 (en) | Compositon for the treatment of aphthas and mouth ulcers | |
| CN101647954B (en) | Traditional Chinese medicine for treating cervicitis and preparation method and application thereof | |
| CN113633738A (en) | Traditional Chinese medicine spray | |
| CN105030813B (en) | A kind of compound preparation for being used to treat sheep mouth inflammation | |
| CN110051723A (en) | A kind of fructus hippophae mouthspray and preparation method thereof | |
| CN109646591B (en) | Composition for oral cavity and application thereof | |
| RU2754828C1 (en) | Dental gel for treatment of inflammatory diseases of periodontal and mucosa of oral cavity, arising on background of psychoemotional stress | |
| RU2751809C1 (en) | Method for treatment of periodontitis | |
| CN107753931A (en) | The preparation and application of nisin, Cetylpyridinium Chloride and sodium fluoride compound gel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20181116 Termination date: 20200611 |